BZX-12668-61178
3 vaccinations
4 coded responses
25 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 980 / WA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-26
- 2020-12-28
- 2020-12-29
- 2021-01-07
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Paranasal sinus discomfort — Feeling: FairFree text: Sinus pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
- 2021-02-15
- 2021-04-12
-
2021-07-12
Survey response — 6 months, dose 2MedDRA: Diarrhoea, Vomiting — Feeling: Poor · Be unable to work or attend schoolFree text: Vomiting and diarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-27
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-28
- 2021-09-29
- 2021-09-30
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
-
2021-12-27
Survey response — 3 months, dose 3MedDRA: Cough, Headache, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cough, congestion, runny nose, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-04-04
Survey response — 6 months, dose 3MedDRA: Pregnancy, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend schoolFree text: Pregnant, positive home antigen for COVID-19MedDRA releases: 2024-11 · check-in free text available
- 2022-09-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | Flu |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Sinus pressure
Release 9 — 6 months, dose 2
Symptoms: Vomiting and diarrhea
Release 10 — 3 months, dose 3
Symptoms: Cough, congestion, runny nose, headache
Release 11 — 6 months, dose 3
Symptoms: Pregnant, positive home antigen for COVID-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release